Editor's Choice
Microbiome Times
Pharma & Human Health
New Study Finds Key Factors That Shape the Skin Microbiome, Including Age and Lifestyle Choices
Scientists are advancing our understanding of how the skin microbiome—the diverse community of bacteria, fungi, and other microbes living on the skin’s surface—is important for skin health. Knowing what shapes the skin microbiome may provide […]
Pharma & Human Health
Ken Blount, CSO of Rebiotix Appointed Chairman of MTIG
The Microbiome Therapeutics Innovation Group (MTIG) announced today the appointment of a new chairman, Ken Blount, Ph.D., Chief Scientific Officer of Rebiotix, Inc. Dr. Blount replaces Tom DesRosier, Esq., Chief Legal Officer of Seres Therapeutics, […]
Pharma & Human Health
New Research shows link between Parkinson’s disease and the microbiome
A simple saliva swab may provide an accurate way of detecting Parkinson’s disease in its earliest stages, according to a study just published in the journal Plos One. In a paper titled “The oral microbiome […]
Animal Health
Elanco Announces R&D Collaboration with AgBiome for Swine Nutritional Health Innovation
Elanco Animal Health Incorporated (NYSE: ELAN), announced today a new global R&D collaboration with AgBiome, Inc. to develop nutritional health products for swine. The collaboration further demonstrates Elanco’s commitment to antibiotic stewardship and bringing alternatives […]
Animal Health
MicroSintesis Announces $16.4M Investment to Fund International Expansion and Material R&D Pipeline
Investment in the company’s microbiome platform will propel the global launch of breakthrough products for livestock, companion animal and human health: MicroSintesis, a life science company focused on developing proprietary microbiome therapies today, at the Vet […]
Finance
DayTwo Secures $31 Million In Series B Financing To Scale Microbiome Research Platform To Address Chronic Health Conditions
DayTwo, the microbiome human discovery platform that offers a glycemic control solution for people with type 2 diabetes, announced $31 Million in Series B financing. DayTwo will use the funding to accelerate go-to-market initiatives in […]
Finance
Axial Biotherapeutics Announces $10M Investment from Taiho Ventures
Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted therapeutics for neurodegenerative diseases and neurodevelopmental disorders, announced a direct investment of $10 million from Taiho Ventures, LLC to fund the discovery […]
Pharma & Human Health
OxThera Initiates Extension Part of a Phase 3 Study of Oxabact in Primary Hyperoxaluria
OxThera AB, a biopharmaceutical company dedicated to improve the lives of people living with Primary Hyperoxaluria, today announced that the first patients in a Phase 3 study of Oxabact® have completed the study and transitioned […]
Finance
DermBiont Raises $8M Series A to Treat the Root Cause of Skin Diseases
DermBiont, a clinical stage therapeutics company dedicated to the discovery and development of live bacterial products for the treatment of skin diseases has closed an $8M Series A. The funding round was led by Zola […]
Finance
Intralytix, Eliava Foundation and Ferring Sign Joint Collaboration Agreement
Intralytix, Inc., announced today that is has entered into a joint collaboration agreement with the Eliava Foundation and Ferring Pharmaceuticals to develop and commercialize new and innovative bacteriophage-based drugs in the field of Reproductive Medicine […]